Abstract
Abstract Objectives: A randomized controlled trial (RCT) and an extension trial of qigong (Chaoyi Fanhuan qigong
[CFQ]) in patients with fibromyalgia were recently completed. In the
present study, a qualitative analysis of comments from the RCT was
undertaken using motivation and amount of practice to determine whether
initial experiences provided information relevant to outcomes.
Intervention: Participants in the RCT received instruction in qigong
(level 1 CFQ), practiced 45 min/day for 8 weeks and continued practice
to 6 months; open-ended qualitative comments on experiences were invited
at 8 weeks and 4 and 6 months. Extension trial participants received
further instruction (level 2 CFQ) and practiced regularly for 8 weeks-6
months. Comments from the original RCT were considered as narratives for
the extension trial subgroup (n=20) and thematically, according to
amount of practice, for all participants who completed the RCT (n=73).
Results: Narrative comments from the RCT for those who completed the
extension trial (n=13) and those who withdrew from that trial (n=7) were
considered separately. Participants reporting benefits within the first
8 weeks were more likely to maintain practice and report continued
benefits at 4-6 months than those who withdrew from the trial. Thematic
comments for all who completed the RCT (n=73) were considered in
relation to amount of practice (per protocol, intermediate, minimal).
Participants who practiced per protocol during the initial 8 weeks (≥5
hours/wk) were more likely to maintain practice over 4-6 months and to
report beneficial health effects from qigong. Conclusions: This retrospective qualitative analysis of information collected in an RCT of qigong
for fibromyalgia indicates that favorable initial experiences with the
practice over 8 weeks predispose to continued practice and more health
effects. Future individual trials and meta-analyses of qigong will need to attend to the amount, and potentially quality, of practice undertaken in considering trial outcomes.
- PMID:
- 25072523
- [PubMed - as supplied by publisher]
No comments:
Post a Comment